TrademarkDir
DSX THERAPEUTICS
DEAD

Serial Number

78716944

Owner

DSX THERAPEUTICS, LLC

Attorney

THEODORE J. BIELEN, JR.

Filing Date

Sep 20, 2005

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DSX THERAPEUTICS Trademark

Serial Number: 78716944

DSX THERAPEUTICS is a trademark filed by DSX THERAPEUTICS, LLC on September 20, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

DSX THERAPEUTICS, LLC (3 trademarks)

601 University Ave. Ste. 278
Sacramento, CA 95825

Entity Type: 16

Trademark Details

Filing Date

September 20, 2005

Registration Date

Not Registered

Published for Opposition

August 22, 2006

Goods & Services

Pharmaceutical preparations for human use namely for the treatment of cardio-vascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 3, 2007 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 3, 2007 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 14, 2006 NOAM
PUBLISHED FOR OPPOSITION
Aug 22, 2006 PUBO
NOTICE OF PUBLICATION
Aug 2, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 29, 2006 PREV
ASSIGNED TO LIE
Jun 16, 2006 ALIE
EXAMINERS AMENDMENT MAILED
Jun 9, 2006 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2006 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 8, 2006 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jun 8, 2006 CNEA
AMENDMENT FROM APPLICANT ENTERED
Jun 5, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2006 CRFA
PAPER RECEIVED
May 15, 2006 MAIL
NON-FINAL ACTION MAILED
Feb 27, 2006 CNRT
NON-FINAL ACTION WRITTEN
Feb 24, 2006 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2006 DOCK
NEW APPLICATION ENTERED
Sep 27, 2005 NWAP

Related Trademarks

More from this Owner

ASEPTIMAB

ASEPTIMAB

ASEPTIMAB

ASEPTIMAB

ASEPTIMAB

ASEPTIMAB

DSX THERAPEUTICS

DSX THERAPEUTICS

DSX THERAPEUTICS

DSX THERAPEUTICS

DSX THERAPEUTICS

DSX THERAPEUTICS